Sophy® tablets

Sophy® tablets
Product Description

Sophy® tablets Sophy® is a clinically proven food supplement designed for women with Polycystic Ovary Syndrome (PCOS). It harnesses the power of Berberine Phytosome®, a berberine–phospholipid complex that enhances absorption and delivers 10 times higher bioavailability compared to standard berberine. This innovation allows Sophy® to maximize berberine’s known metabolic, hormonal, and anti-inflammatory benefits. PCOS is characterized by menstrual irregularities, ovarian cysts, acne, insulin resistance, and hyperandrogenism. In a multicenter, randomized, controlled clinical trial involving 106 women, Sophy® significantly reduced all main PCOS symptoms after 3 months: menstrual disorders decreased by 80%, ovarian polycystosis by 70%, and acne by 55%, with no increase in side effects compared to diet alone. By addressing both reproductive and metabolic dimensions of PCOS, Sophy® offers a comprehensive, safe, and well-tolerated option for long-term management. Its efficacy has been recognized internationally, winning the NutraIngredients Awards 2024 in the Botanicals category. With its dual action on hormonal balance and metabolic health, Sophy® represents a new philosophy in PCOS care—effective, natural, and patient-centered

PHARMEXTRACTA S.P.A.

  • Country/Region:
    Italy
  • On CPHI since:
    2020
  • Employees:
    100 - 249
Company types
Distributor/Import Export
Wholesale/Retail

PHARMEXTRACTA S.P.A.

  • Country/Region:
    Italy
  • On CPHI since:
    2020
  • Employees:
    100 - 249
Company types
Distributor/Import Export
Wholesale/Retail

More Products from PHARMEXTRACTA S.P.A. (7)

  • Berberol®

    Product Berberol®

    Berberol® is the first food supplement containing berberine that overcame the issue of the very poor bioavailability of this botanical ingredient thanks to its patented formulation featuring Silymarin. The effectiveness of this supplement in blood sugar and blood fat control has been confirmed by several ...
  • Colipral® capsules

    Product Colipral® capsules

    Colipral® capsules Colipral® is an innovative probiotic supplement developed with Escherichia coli 5C (ECP24®), a thoroughly characterized and genomically safe strain of human origin. Each enteric-coated capsule delivers a high concentration of at least 1×10⁹ CFU, ensuring the microorganism reaches the in...
  • Bactorinol®

    Product Bactorinol®

    Bactorinol® nasal drops contains Winterized Lentisk Oil a novel ingredient with antibacterial activity, able to disrupt bacterial biofilms to eradicate biofilm-related infections of the upper respiratory tract.

    To be used alone or as add-on therapy to antibiotic therapies.
  • Berberol®

    Product Berberol®

    Berberol® is the first food supplement containing berberine that overcame the issue of the very poor bioavailability of this botanical ingredient thanks to its patented formulation featuring Silymarin.

    The effectiveness of this supplement in blood sugar and blood fat control has been confirmed b...
  • Brevicillin®

    Product Brevicillin®

    Brevicillin® is a food supplement in sticks containing the probiotic strain Bifidobacterium breve PRL2020.

    Each stick contains at least 15 billion CFU (colony forming units) of Bifidobacterium breve PRL2020, useful for the balance of gut bacterial flora in case of antibiotic therapy.

    ...
  • Crispact®

    Product Crispact®

    Crispact® is a food supplement in stick packs containing the probiotic strain Lactobacillus crispatus M247.

    Each stick pack contains at least 20 billion CFUs(colony forming units) of Lactobacillus crispatusM247, useful for the balance of bacterial flora.

    https://...
  • Mirgeal® gel

    Product Mirgeal® gel

    Mirgeal® gel is an innovative food supplement that rapidly relieves symptoms related to acid reflux performing better than alginate with long-term benefits.

    Mirgeal® gel contains licorice extract, documented for its anti-inflammatory and anti-ulcer properties, and Mirtoselect®, a special blueber...

PHARMEXTRACTA S.P.A. resources (9)